Document is current
Any future updates will be listed below
-
Authors
da Silva, Bruna S.
Leffa, Douglas T.
Beys-da-Silva, Walter O. https://orcid.org/0000-0001-8329-7839
Torres, Iraci L. S. https://orcid.org/0000-0002-3081-115X
Rovaris, Diego L.
Victor, Marcelo M.
Rohde, Luis A.
Mota, Nina R. https://orcid.org/0000-0003-3504-759X
Oliveira, Carla de
Berger, Markus
Yates, John R. III https://orcid.org/0000-0001-5267-1672
Sabnis, Renuka
Peña, Ramón Díaz
Campos, Alexandre Rosa
Grevet, Eugenio H.
Santi, Lucelia https://orcid.org/0000-0002-5698-7006
Bau, Claiton H. D.
Contini, Verônica
- License Information
-
More Information
Article History
Received: 27 September 2019
Revised: 9 October 2019
Accepted: 1 November 2019
First Online: 18 November 2019
Conflict of interest
: The author(s) declare the following potential conflict of interest with respect to the research, authorship and/or publication of this article: Dr. Grevet was on the speaker’s bureau for Novartis and Shire for the last 3 years. He also received travel awards (air tickets and hotel accommodations) for participating in two psychiatric meetings from Shire and Novartis. Dr. Rohde has been on the speakers’ bureau/advisory board and/or has acted as a consultant for Medice, Novartis/Sandoz and Shire/Takeda in the last three years. He receives authorship royalties from Oxford Press and ArtMed. He also received travel awards for taking part of 2016 AACAP meeting from Novartis and 2018 APA meeting from Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Janssen-Cilag, Medice, Novartis/Sandoz, and Shire/Takeda. All other authors have nothing to disclose.
